Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple Sclerosis

BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients

NCT00099502 ·Status: COMPLETED ·Phase: PHASE3

BEYOND Pilot Study

NCT00893217 ·Status: COMPLETED ·Phase: PHASE2

Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b

NCT03408093 ·Status: COMPLETED

Telephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial.

NCT01031459 ·Status: COMPLETED

Follow-up Study After 11 Years of Patients Who Were Included in the BENEFIT Trial (304747) With a First Demyelinating Event Suggestive of Multiple Sclerosis

NCT01795872 ·Status: COMPLETED ·Phase: PHASE4

Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot Study

NCT03134573 ·Status: COMPLETED

Physical Disability in Patients Treated With Betaferon

NCT00873340 ·Status: COMPLETED

BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose

NCT00459667 ·Status: COMPLETED ·Phase: PHASE3

US PROmyBETAapp2.0: A Study to Learn More About the Medication Usage and Patient Reported Outcomes Via the myBETAapp in Medical Care of Patients With Multiple Sclerosis Treated With BETASERON Using BETACONNECT Autoinjector

NCT04356339 ·Status: COMPLETED

Rehabilitation Study in MS Patients

NCT00780455 ·Status: TERMINATED ·Phase: PHASE4

Safety Study in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or Rebif

NCT00317941 ·Status: COMPLETED ·Phase: PHASE4

Study to Compare Double-dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS)

NCT00313976 ·Status: WITHDRAWN ·Phase: PHASE3

An Observational Study of Multiple Sclerosis (MS) Patients Starting or Restarting Baseline Treatment With Interferon Beta 1a After the Use of Escalation Treatment With Mitoxantrone

NCT01142518 ·Status: COMPLETED

BetaPlus Survey - Observational Study to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon® by Using Elements of the BetaPlus Program

NCT01233245 ·Status: COMPLETED

Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMS

NCT00202995 ·Status: TERMINATED ·Phase: PHASE4

Costs, Quality of Life and Functional Outcomes in Veterans Treated for Multiple Sclerosis With Beta-Interferon l-B (Betaseron)

NCT00439257 ·Status: COMPLETED

Injection Management With Betaferon: Influence on Adherence, Patients Satisfaction and Health Related Outcomes (BETAPATH)

NCT00902135 ·Status: COMPLETED

BENEFIT Extension Study

NCT00544037 ·Status: COMPLETED

Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis

NCT01491100 ·Status: COMPLETED

A Study to Evaluate Rebif® New Formulation (Interferon-beta-1a) in Relapsing Remitting Multiple Sclerosis

NCT00441103 ·Status: COMPLETED ·Phase: PHASE3

Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment

NCT00787657 ·Status: COMPLETED

BAY86-5046 (Betaseron), Non Interventional Studies

NCT02121444 ·Status: COMPLETED

Prospective, Multicenter Non Interventional Study to Evaluate Adherence to Betaferon Over a 2 Years Period

NCT01076595 ·Status: COMPLETED

Evaluation of Risk Factors for Early Termination of Injection Treatment With Betaferon in Patients Suffering From Multiple Sclerosis

NCT01184833 ·Status: COMPLETED

Open, Multicentric, Prospective, Quality of Life Study in Multiple Sclerosis Patients

NCT00928967 ·Status: COMPLETED